20
Copperhead Investments Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SDM-17 (10% NITROGLYCERIN IN LACTOSE), with a corresponding US DMF Number 1839.
Remarkably, this DMF maintains an Active status since its submission on December 16, 1971, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 15, 2013, and payment made on March 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II